In addition, the therapeutic payload encapsulated in our nanosystem can function for synergistic effect as high infiltration of DCs in the tumor microenvironment due to MIP‐3α can boost the therapeutic effect of R848 on triggering DC maturation. This evidence concerns the gene CCL20 and neoplasm.